| HS编码 | 商品名称 | 退税率 | 计量单位 | 海关监管 | 申报要素·检疫 | 编码对比 |
| 30019090.19 | 非濒危蛇毒制品
[Non-endangered snake venom (for therapeutic or prophy-lacticuse )] |
千克/无 | AQB | 查看详情 | -- | |
| 30019090.20 | 含有人类遗传资源的人体制品
[Human body products containing human genetic resources] |
13.0% | 千克/无 | ABQV | 查看详情 | 对比-30019090.19 |
| 30019090.91 | 其他濒危动物制品
[Other substances of endangered animal, prepared for therapeutic or prophylactic uses] |
0.0% | 千克/无 | ABFEQ | 查看详情 | 对比-30019090.20 |
| 30019090.92 | 人类腺体、器官、组织
[Human glands, organs, tissues] |
13.0% | 千克/无 | AB | 查看详情 | 对比-30019090.91 |
| 30019090.99 | 其他未列名的人体或动物制品
[Other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included] |
9.0% | 千克/无 | ABQ | 查看详情 | 对比-30019090.92 |
| 30021200.23 | 含有人类遗传资源的抗血清及其他血份
[Antiserum and other blood containing human genetic resources] |
13.0% | 千克/无 | ABV | 查看详情 | 对比-30019090.99 |
| 30021200.30 | 兽用血清制品
[Veterinary serum products] |
13 | 千克/无 | ABR | 查看详情 | 对比-30021200.23 |
| 30021200.93 | 罕见病药品制剂
[Rare disease drug preparation(Including the first and second batch of related products on the rare disease drug list)] |
13 | 千克/无 | AB | 查看详情 | 对比-30021200.30 |
| 30021200.94 | 其他含濒危动物成分的抗血清及血份
[Other antisera and other blood fractions of endangered ani-mals] |
千克/无 | ABEF | 查看详情 | 对比-30021200.93 | |
| 30021200.99 | 其他抗血清及其他血份
[Other anti-serum and other blood types due to the resolution of anti-cancer drugs] |
13.0% | 千克/无 | AB | 查看详情 | 对比-30021200.94 |
| 30021300.10 | 非混合的《兴奋剂目录》所列蛋白同化制剂和肽类激素免疫制品，未配定剂量或制成零售包装
[Non mixed protein assimilates and peptide hormone immune products listed in the "Catalogue of Doping Agents", without dosage or made into retail packaging] |
13% | 千克/无 | ABL | 查看详情 | 对比-30021200.99 |
| 30021300.90 | 其他非混合的免疫制品，未配定剂量或制成零售包装
[Other non mixed immune products, not formulated in dosage or made into retail packaging] |
13% | 千克/无 | AB | 查看详情 | 对比-30021300.10 |
| 30021400.00 | 混合的免疫制品，未配定剂量或制成零售包装
[Immunological products，mixed，not put up in measured doses or in forms or packings for retail sale] |
13% | 千克/无 | AB | 查看详情 | 对比-30021300.90 |
| 30021500.10 | 抗（防）癌药品制剂（不含癌症辅助治疗药品）
[Immunological products，put up in measured doses or in forms or packings for retail sale] |
13% | 千克/无 | AB | 查看详情 | 对比-30021400.00 |
| 30021500.30 | 罕见病药品制剂
[Rare disease drug preparations.] |
13% | 千克/无 | AB | 查看详情 | 对比-30021500.10 |
| 30021500.40 | 兽用免疫学体内诊断制品（已配剂量的）
[Veterinary immunology in vivo diagnostic products (with dosage already prepared)] |
13% | 千克/无 | ABR | 查看详情 | 对比-30021500.30 |
| 30021500.50 | 《兴奋剂目录》所列蛋白同化制剂和肽类激素免疫制品，已配定剂量或制成零售包装
[The protein assimilation agents and peptide hormone immune products listed in the "Catalogue of Doping Agents" have been formulated in doses or made into retail packaging] |
13% | 千克/无 | ABL | 查看详情 | 对比-30021500.40 |
| 30021500.90 | 其他免疫制品，已配定剂量或制成零售包装
[Immunological products，put up in measured doses or in forms or packings for retail sale] |
13% | 千克/无 | AB | 查看详情 | 对比-30021500.50 |
| 30024100.11 | 新型冠状病毒（COVID-19）疫苗，已配定剂量或制成零售包装
[The novel coronavirus (COVID-19) vaccine has been dosed or made into retail packaging] |
13% | 千克/无 | QAB | 查看详情 | 对比-30021500.90 |
| 30024100.19 | 新型冠状病毒（COVID-19）疫苗，未配定剂量或制成零售包装
[Novel coronavirus (COVID-19) vaccine, not dosed or made into retail packaging] |
13% | 千克/无 | QAB | 查看详情 | 对比-30024100.11 |